Friday, July 10, 2026

Drug profile · INN

givinostat

givinostat (DUVYZAT) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Musculo-skeletal system (M09) M09AX14
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — givinostat
Class
Musculo-skeletal system (M09)
Route
Patents
0
Programs
3
Data quality
0.83

Quick answer

givinostat (DUVYZAT) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN givinostat
Brand DUVYZAT
Therapeutic class Musculo-skeletal system (M09)
ATC code M09AX14

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. DSC/08/2357/32 Phase 3 · ITALFARMACO S.P.A · JAK2V617F-positive high-risk Polycythemia Vera
  2. DSC/14/2357/50 Phase 3 · ITALFARMACO S.P.A · Duchenne muscular dystrophy (DMD)
  3. DSC/11/2357/44 Phase 2 · ITALFARMACO S.P.A · Chronic myeloproliferative neoplasm

Related & competitor drugs

  1. allopurinol Musculo-skeletal system (M04)
  2. colchicine Musculo-skeletal system (M04)
  3. denosumab Musculo-skeletal system (M05)
  4. eteplirsen Musculo-skeletal system (M09)
  5. febuxostat Musculo-skeletal system (M04)
  6. ibandronic acid Musculo-skeletal system (M05)

Frequently asked questions

What is givinostat?

givinostat (DUVYZAT) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for givinostat?

DUVYZAT is a marketed brand name for givinostat. Check FDA Drugs@FDA for the current US label holder and prescribing information.